Growth differentiation factor GDF11 as a potential target for the treatment of age-related diseases
- Авторлар: Kurkin D.1,2, Bakulin D.1,2, Morkovin E.1, Strygin A.1, Petrov V.1, Robertus A.2, Ivanova O.2, Kolosov Y.2
-
Мекемелер:
- Volgograd State Medical University
- Moscow State Medical and Dental University named after A.I. Evdokimov
- Шығарылым: Том 55, № 1 (2024)
- Беттер: 47–62
- Бөлім: Articles
- URL: https://journals.rcsi.science/0301-1798/article/view/255711
- DOI: https://doi.org/10.31857/S0301179824010056
- ID: 255711
Дәйексөз келтіру
Аннотация
The article presents a review of literary sources dedicated to the physiological role and functions of certain proteins of the TGFβ superfamily, specifically GDF11 and GDF8, as well as their place in the pathogenesis of several diseases whose risk increases with age. Possible therapeutic applications of these proteins are described. It is shown that the role of GDF11 in the pathogenesis of the described diseases is ambiguous. GDF11 is a previously unrecognized regulator of bone remodeling, prevents myocardial hypertrophy, and improves the condition of animals with experimental diabetes or neurodegeneration. The anti-proliferative action of GDF11 is also observed in many oncological diseases. However, GDF11 may have a negative impact on the metabolism of muscle and bone tissue, which may limit its use in certain conditions. Due to differences in the expression and function of GDF11 in cardiac, nervous, muscular, and other tissues, its divergent actions, and the narrow therapeutic range of recombinant GDF11, further research is needed to determine the optimal range of indications and limitations, dosages, and methods to reduce side effects.
Негізгі сөздер
Толық мәтін
Авторлар туралы
D. Kurkin
Volgograd State Medical University; Moscow State Medical and Dental University named after A.I. Evdokimov
Хат алмасуға жауапты Автор.
Email: strannik986@mail.ru
Ресей, 400087, Volgograd; 127473, Moscow
D. Bakulin
Volgograd State Medical University; Moscow State Medical and Dental University named after A.I. Evdokimov
Email: strannik986@mail.ru
Ресей, 400087, Volgograd; 127473, Moscow
E. Morkovin
Volgograd State Medical University
Email: strannik986@mail.ru
Ресей, 400087, Volgograd
A. Strygin
Volgograd State Medical University
Email: strannik986@mail.ru
Ресей, 400087, Volgograd
V. Petrov
Volgograd State Medical University
Email: strannik986@mail.ru
Ресей, 400087, Volgograd
A. Robertus
Moscow State Medical and Dental University named after A.I. Evdokimov
Email: strannik986@mail.ru
Ресей, 127473, Moscow
O. Ivanova
Moscow State Medical and Dental University named after A.I. Evdokimov
Email: strannik986@mail.ru
Ресей, 127473, Moscow
Yu. Kolosov
Moscow State Medical and Dental University named after A.I. Evdokimov
Email: strannik986@mail.ru
Ресей, 127473, Moscow
Әдебиет тізімі
- Айтбаев К. А., Муркамилов И.Т., Муркамилова Ж.А. и др. Регуляция иммунной системы при старении: в фокусе-эпигенетические механизмы // Архивъ внутренней медицины. 2022. Т. 12. № 1 (63). С. 35.
- Антошкин О.Н., Загребин В.Л., Волотова Е.В. и др. Протеинопатия и апоптоз нейронов головного мозга при экспериментальной нейродегенерации у крыс // Вестник Волгоградского государственного медицинского университета. 2015. № 1 (53). С. 122–124.
- Волкова Ю. Р. Возможности клеточной терапии для коррекции возрастных изменений когнитивных функции центральной нервной системы // Известия Российской Военно-медицинской академии. 2021. Т. 40. № S1–3. С. 64.
- Лебедев А.А., Пузин С.Н., Потапов В.Н. и др. От геронтологии к медицине антистарения // Медико-социальная экспертиза и реабилитация. 2014. № 2. С. 4–6.
- Сагинбаев У.Р., Рукавишникова С.А., Ахмедов Т.А. Организационные и химико-лабораторные аспекты биогеохимических провинций при формировании возраст-ассоциированной сосудистой патологии // Клиническая геронтология. 2021. Т. 27. № 11–12. С. 63–69.
- Сойибов И.Э. Клинические особенности травматических внутричерепных кровоизлияний в пожилом возрасте // Клиническая геронтология. 2021. Т. 27. № 11–12. С. 5–9.
- Тюренков И.Н., Бакулин Д.А., Куркин Д.В., Волотова Е.В. Нейропротективные свойства инкретиномиметиков при ишемии головного мозга и нейродегенеративных заболеваниях // Проблемы эндокринологии. 2017. Т. 63. № 1. С. 58–67. https://doi.org/10.14341/probl201763149-58
- Тюренков И.Н., Бакулин Д.А., Смирнов А.В. и др. Нейропротективные свойства ГАМК и ее производных при диабетической энцефалопатии у старых животных. Фармация и фармакология. 2023. Т. 11. № 3. С. 211–227. https://doi.org/10.19163/2307-9266-2023-11-3-211-227
- Тюренков И.Н., Волотова Е.В., Куркин Д.В., Бакулин Д.А. Течение ишемии головного мозга у животных с недостаточностью половых гормонов и эндотелиальной дисфункцией // Обзоры по клинической фармакологии и лекарственной терапии. 2019. Т. 17. № 1. С. 57–64. https://doi.org/10.7816/rcf17157-64
- Шиловский Г.А., Сорокина Е.В., Орловский И.В. Транскрипционный фактор nrf2 – мишень активирующих антиоксидантную систему клетки препаратов: перспективы применения при возрастных заболеваниях // Клиническая геронтология. 2021. Т. 27. № 11–12. С. 57–62.
- Ahn S.T., Suh S.I., Moon H. et al. Evaluation of growth differentiation factor 11 (GDF11) levels in dogs with chronic mitral valve insufficiency // Can J Vet Res. 2016. V. 80. № 1. P. 90–92.
- Akhurst R.J., Padgett R.W. Matters of context guide future research in TGFβ superfamily signaling // Science signaling. 2015. V. 8. № 399. P. re10. https://doi.org/10.1126/scisignal.aad0416
- Añón-Hidalgo J., Catalán V., Rodríguez A. et al. Circulating GDF11 levels are decreased with age but are unchanged with obesity and type 2 diabetes // Aging (Albany NY). 2019. V. 11. № 6. P. 1733–1744. https://doi.org/10.18632/aging.101865
- Anqi X., Ruiqi C., Yanming R. et al. Neuroprotective potential of GDF11 in experimental intracerebral hemorrhage in elderly rats // J. Clin. Neurosci. 2019. № 63. P. 182. https://doi.org/10.1016/j.jocn.2019.02.016
- Avilion A.A., Nicolis S.K., Pevny L.H. et al. Multipotent cell lineages in early mouse development depend on SOX2 function // Genes. Dev. 2003. V. 17. № 1. P. 126. https://doi.org/10.1101/gad.224503
- Bajikar S.S., Wang C.C., Borten M.A. et al. Tumor-suppressor inactivation of GDF11 occurs by precursor sequestration in triple-negative breast cancer // Dev. Cell. 2017. V. 43. № 4. P. 418. https://doi.org/10.1016/j.devcel.2017.10.027
- Bernstein Z.S., Kim E.B., Raje N. Bone disease in multiple myeloma: biologic and clinical implications // Cells. 2022. V. 11. № 15. P. 2308. https://doi.org/10.3390/cells11152308
- Brun C.E., Rudnicki M.A. GDF11 and the mythical fountain of youth // Cell Metab. 2015. V. 22. №1. P. 54. https://doi.org/10.1016/j.cmet.2015.05.009
- Bueno J.L., Ynigo M., de Miguel C. et al. Growth differentiation factor 11 (GDF11) – a promising anti-ageing factor - is highly concentrated in platelets // Vox Sang. 2016. V. 111. № 4. P. 434–436. https://doi.org/10.1111/vox.12438
- Camparini L., Kollipara L., Sinagra G. et al. Targeted approach to distinguish and determine absolute levels of GDF8 and GDF11 in mouse serum // Proteomics. 2020. V. 20. № 11. P. 1900104. https://doi.org/10.1002/pmic.201900104
- Caporali A., Meloni M., Nailor A. et al. p75(NTR)-dependent activation of NF-κB regulates microRNA-503 transcription and pericyte-endothelial crosstalk in diabetes after limb ischaemia // Nat. Commun. 2015. № 6. P. 8024. https://doi.org/10.1038/ncomms9024
- Chen W.J., Ten Dijke P. Immunoregulation by members of the TGFβ superfamily // Nat. Rev. Immunol. 2016. V. 16. № 12. P. 723. https://doi.org/10.1038/nri.2016.112
- Chen Y., Guo Q., Zhang M. et al. Relationship of serum GDF11 levels with bone mineral density and bone turnover markers in postmenopausal Chinese women // Bone Res. 2016. V. 4. P. 16012. https://doi.org/10.1038/boneres.2016.12
- Conboy I.M., Conboy M.J., Wagers A.J. et al. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature. 2005. V. 433. № 7027. P. 760. https://doi.org/10.1038/nature03260
- Conboy M.J., Conboy I.M., Rando T.A. Heterochronic parabiosis: historical perspective and methodological considerations for studies of aging and longevity // Aging Cell. 2013. V. 12. № 3. P. 525. https://doi.org/10.1111/acel.12065
- Conese M., Carbone A., Beccia E. et al. The fountain of youth: a tale of parabiosis, stem cells, and rejuvenation // Open Med (Wars). 2017. № 12. P. 376. https://doi.org/10.1515/med-2017-0053
- De Domenico E., D’Arcangelo G., Faraoni I., et al. Modulation of GDF11 expression and synaptic plasticity by age and training // Oncotarget. 2017. V. 8. № 35. P. 57991. https://doi.org/10.18632/oncotarget.19854
- Duan F., Wang X., Wang H. et al. GDF11 ameliorates severe acute pancreatitis through modulating macrophage M1 and M2 polarization by targeting the TGFβR1/SMAD-2 pathway // Int. Immunopharmacol. 2022. V. 108. P. 108777. https://doi.org/10.1016/j.intimp.2022.108777
- Duran J., Troncoso M.F., Lagos D. et al. GDF11 Modulates Ca2+-Dependent Smad2/3 Signaling to Prevent Cardiomyocyte Hypertrophy // Int. J. Mol. Sci. 2018. V. 19. № 5. P. 1508. https://doi.org/10.3390/ijms19051508
- Egerman M.A., Cadena S.M., Gilbert J.A. et al. GDF11 Increases with Age and Inhibits Skeletal Muscle Regeneration // Cell. Metab. 2015. V. 22. № 1. P. 164. https://doi.org/10.1016/j.cmet.2015.05.010
- Egerman M.A., Glass D.J. Signaling pathways controlling skeletal muscle mass // Crit. Rev. Biochem. Mol. Biol. 2014. V. 49. № 1. P. 59. https://doi.org/10.3109/10409238.2013.857291
- Egerman M.A., Glass D.J. The role of GDF11 in aging and skeletal muscle, cardiac and bone homeostasis // Crit. Rev. Biochem. Mol. Biol. 2019. V. 54. № 2. P. 174. https://doi.org/10.1080/10409238.2019.1610722
- Eggel A., Wyss-Coray T. A revival of parabiosis in biomedical research // Swiss Med. Wkly. 2014. № 144. P. w13914. https://doi.org/10.4414/smw.2014.13914
- Emanueli C., Salis M.B., Pinna A. et al. Prevention of diabetes-induced microangiopathy by human tissue kallikrein gene transfer // Circulation. 2002. V. 106. № 8. P. 993. https://doi.org/10.1161/01.cir.0000027104.33206.c8
- Escobedo-Calvario A., Chávez-Rodríguez L., Souza V. et al. The effect of growth differentiation factor 11 (GDF11) on the response of tumor-associated macrophages in hepatocellular carcinoma derived cells // Ann. Hepatol. 2022. V. 27. P. 100631. https://doi.org/10.1016/j.aohep.2021.100631
- Essalmani R., Zaid A., Marcinkiewicz J. et al. In vivo functions of the proprotein convertase PC5/6 during mouse development: Gdf11 is a likely substrate // Proc. Natl. Acad. Sci. USA. 2008. V. 105. № 15. P. 5750. https://doi.org/10.1073/pnas.0709428105
- Fang Z., Zhu Z., Zhang H. et al. GDF11 contributes to hepatic hepcidin (HAMP) inhibition through SMURF1‐mediated BMP‐SMAD signalling suppression // Brit. J. Haematol. 2020. V. 188. № 2. P. 321. https://doi.org/10.1111/bjh.16156
- Freitas-Rodríguez S., Rodríguez F., Folgueras A.R. GDF11 administration does not extend lifespan in a mouse model of premature aging // Oncotarget. 2016. V. 7 № 35. P. 55951. https://doi.org/10.18632/oncotarget.11096
- Garrido-Moreno V., Díaz-Vegas A., López-Crisosto C. et al. GDF-11 prevents cardiomyocyte hypertrophy by maintaining the sarcoplasmic reticulum-mitochondria communication // Pharmacol. Res. 2019. V. 146. P. 104273. https://doi.org/10.1016/j.phrs.2019.104273
- Gerardo-Ramírez M., Lazzarini-Lechuga R., Hernández-Rizo S. et al. GDF11 exhibits tumor suppressive properties in hepatocellular carcinoma cells by restricting clonal expansion and invasion // Biochim. Biophys. Acta Mol. Basis Dis. 2019. V. 1865. № 6. P. 1540. https://doi.org/10.1016/j.bbadis.2019.03.003
- Glass D.J. Elevated GDF11 is a risk factor for age-related frailty and disease in humans // Cell. Metabol. 2016. V. 24. № 1. P. 7. https://doi.org/10.1016/j.cmet.2016.06.017
- Gu B., Wang Q., Dai W. et al. Effect of GDF11 on proliferation and apoptosis of esophageal cancer cells // Cell. Mol. Biol. 2018. V. 64. № 11. P. 80.
- Hammers D.W., Merscham-Banda M., Hsiao J.Y. et al. Supraphysiological levels of GDF11 induce striated muscle atrophy // EMBO Mol. Med. 2017. V. 9. № 4. P. 531. https://doi.org/10.15252/emmm.201607231
- Han W., Bai X.J., Han L.L. et al. The relationship between transforming growth factor β superfamily members (GDF11 and BMP4) and lumbar spine bone mineral density in postmenopausal Chinese women // Arch. Gynecol. Obstet. 2022. V. 305. № 3. P. 737. https://doi.org/10.1007/s00404-021-06183-8
- Harmon E.B., Apelqvist A.A., Smart N.G. et al. GDF11 modulates NGN3+ islet progenitor cell number and promotes beta-cell differentiation in pancreas development // Development. 2004. V. 131. № 24. P. 6163. https://doi.org/10.1242/dev.01535
- Harper S.C., Brack A., MacDonnell S. et al. Is Growth Differentiation Factor 11 a Realistic Therapeutic for Aging-Dependent Muscle Defects? // Circ. Res. 2016. V. 118. № 7. P. 1143. https://doi.org/10.1161/CIRCRESAHA.116.307962
- Hinken A.C., Powers J.M., Luo G. et al. Lack of evidence fOr GDF11 as a rejuvenator of aged skeletal muscle satellite cells // Aging Cell. 2016. V. 15. № 3. P. 582–584. https://doi.org/10.1111/acel.12475
- Hu H.H., Chen D.Q., Wang Y.N. et al. New insights into TGF-β/Smad signaling in tissue fibrosis // Chem. Biol. Int. 2018. V. 292. P. 76. https://doi.org/10.1016/j.cbi.2018.07.008
- Jaeger P.A., Lucin K.M., Britschgi M. et al. Network-driven plasma proteomics expose molecular changes in the Alzheimer’s brain // Mol. Neurodegener. 2016. № 11. P. 31. https://doi.org/10.1186/s13024-016-0095-2
- Kaiser J. Aging. ‘Rejuvenation factor’ in blood turns back the clock in old mice // Science. 2014. V. 344. № 6184. P. 570. https://doi.org/10.1126/science.344.6184.570
- Kalampouka I., van Bekhoven A., Elliott B.T. differing effects of younger and older human plasma on C2C12 myocytes in vitro // Front. Physiol. 2018. V. 9. P. 152. https://doi.org/10.3389/fphys.2018.00152
- Katsimpardi L., Litterman N.K., Schein P.A. et al. Vascular and neurogenic rejuvenation of the aging mouse brain by young systemic factors // Science. 2014. V. 344. № 6184. P. 630. https://doi.org/10.1126/science.1251141
- Khavinson, V.K., Kuznik, B.I., Tarnovskaya, S.I. et al. GDF11 protein as a geroprotector // Biol. Bull. Rev. 2016. № 6. P. 141. https://doi.org/10.1134/S207908641602002X
- Kim J., Wu H.H., Lander A.D. et al. GDF11 controls the timing of progenitor cell competence in developing retina // Science. 2005. V. 308. № 5730. P. 1927. https://doi.org/.1126/science.1110175
- Kondás K., Szláma G., Trexler M. et al. Both WFIKKN1 and WFIKKN2 have high affinity for growth and differentiation factors 8 and 11 // J. Biol. Chem. 2008. V. 283. № 35. P. 23677. https://doi.org/10.1074/jbc.M803025200
- Kurkin D.V., Bakulin D.A., Morkovin E.I. et al. Neuroprotective action of cortexin, cerebrolysin and actovegin in acute or chronic brain ischemia in rats // PLoS ONE. 2021. V. 16. № 7. P. e0254493. https://doi.org/10.1371/journal.pone.0254493
- Lananna B.V., Imai S.I. Friends and foes: Extracellular vesicles in aging and rejuvenation // FASEB Bioadv. 2021. V. 3. № 10. P. 787. https://doi.org/10.1096/fba.2021-00077
- Lee Y.J., McPherron A., Choe S. et al. Growth differentiation factor 11 signaling controls retinoic acid activity for axial vertebral development // Dev. Biol. 2010. V. 347. № 1. P. 195. https://doi.org/10.1016/j.ydbio.2010.08.022
- Lee Y.S., Lee S.J. Regulation of GDF-11 and myostatin activity by GASP-1 and GASP-2 // Proc. Natl. Acad. Sci. USA. 2013. V. 110. № 39. P. E3713. https://doi.org/10.1073/pnas.1309907110
- Li H., Li Y., Xiang L. et al. GDF11 Attenuates Development of Type 2 Diabetes via Improvement of Islet β-Cell Function and Survival // Diabetes. 2017. V. 66. № 7. P. 1914. https://doi.org/10.2337/db17-0086
- Li S.N., Wu J.F. TGF-β/SMAD signaling regulation of mesenchymal stem cells in adipocyte commitment // Stem. Cell. Res. Ther. 2020. V. 11. № 1. P. 41. https://doi.org/10.1186/s13287-020-1552-y
- Li Y., Li Y., Li L. et al. The emerging translational potential of GDF11 in chronic wound healing // J. Orth. Trans. 2022. № 34. P. 113. https://doi.org/10.1016/j.jot.2022.03.005
- Li Z., Kawasumi M., Zhao B. et al. Transgenic over-expression of growth differentiation factor 11 propeptide in skeleton results in transformation of the seventh cervical vertebra into a thoracic vertebra // Mol. Reprod. Dev. 2010. V. 77. № 11. P. 990. https://doi.org/10.1002/mrd.21252
- Liu A., Dong W., Peng J. et al. Growth differentiation factor 11 worsens hepatocellular injury and liver regeneration after liver ischemia reperfusion injury // FASEB J. 2018. V. 32. № 9. P. 5186-5198. https://doi.org/10.1096/fj.201800195R
- Liu W., Zhou L., Zhou C. et al. GDF11 decreases bone mass by stimulating osteoclastogenesis and inhibiting osteoblast differentiation // Nat. Commun. 2016. № 7. P. 12794. https://doi.org/10.1038/ncomms12794
- Liu Y., Shao L., Chen K. et al. GDF11 restrains tumor growth by promoting apoptosis in pancreatic cancer // Onco. Targets Ther. 2018. № 11. P. 8371. https://doi.org/10.2147/OTT.S181792
- Loffredo F.S., Steinhauser M.L., Jay S.M. et al. Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy // Cell. 2013. V. 153. № 4. P. 828. https://doi.org/10.1016/j.cell.2013.04.015
- Lu L., Bai X., Cao Y. et al. Growth differentiation factor 11 promotes neurovascular recovery after stroke in mice // Front. Cell. Neurosci. 2018. № 12. P. 205. https://doi.org/10.3389/fncel.2018.00205
- Lu Q., Tu M.L., Li C.J. et al. GDF11 inhibits bone formation by activating Smad2/3 in bone marrow mesenchymal stem cells // Calc. Tissue Int. 2016. V. 99. № 5. P. 500. https://doi.org/10.1007/s00223-016-0173-z
- Ma S., Wang S., Ye Y. et al. Heterochronic parabiosis induces stem cell revitalization and systemic rejuvenation across aged tissues // Cell. Stem. Cell. 2022. V. 29. № 6. P. 990. https://doi.org/10.1016/j.stem.2022.04.017
- Mayack S.R., Shadrach J.L., Kim F.S. et al. Systemic signals regulate ageing and rejuvenation of blood stem cell niches // Nature. 2010. V. 463. № 7280. P. 495. https://doi.org/10.1038/nature08749
- McNally E.M. Questions and answers about myostatin, GDF11, and the aging heart // Circ Res. 2016. V. 118. № 1. P. 6. https://doi.org/10.1161/CIRCRESAHA.115.307861
- McPherron A.C., Lawler A.M., Lee S.J. Regulation of anterior/posterior patterning of the axial skeleton by growth/differentiation factor 11 // Nat. Genet. 1999. № 22. P. 260. https://doi.org/10.1038/10320
- McPherron A.C., Lawler A.M., Lee S.J. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member // Nature. 1997. № 387. P. 83. https://doi.org/10.1038/387083a0
- Mei W., Xiang G., Li Y. et al. GDF11 Protects against endothelial injury and reduces atherosclerotic lesion formation in apolipoprotein e-null mice // Mol. Ther. 2016. V. 24. № 11. P. 1926. https://doi.org/10.1038/mt.2016.160
- Meloux A., Rochette L., Maza M. et al. Growth differentiation factor-8 (GDF8)/myostatin is a predictor of troponin I peak and a marker of clinical severity after acute myocardial infarction // J. Clin. Med. 2019. V. 9. № 1. P. 116. https://doi.org/10.3390/jcm9010116
- Mendez P.L., Obendorf L., Knaus P. Visualization and quantification of TGFβ/BMP/SMAD signaling under different fluid shear stress conditions using proximity-ligation-assay // J. Visual. Exp. 2021. №. 175. P. e62608. https://doi.org/10.3791/62608
- Monestier O., Blanquet V. WFIKKN1 and WFIKKN2: “Companion” proteins regulating TGFB activity // Cytokine Growth Factor Rev. 2016. V. 32. P. 75. https://doi.org/10.1016/j.cytogfr.2016.06.003
- Nagy A., Trexler M., Patthy L. Expression, purification and characterization of the second Kunitz-type protease inhibitor domain of the human WFIKKN protein // Eur. J. Biochem. 2003. V. 270. № 9. P. 2101. https://doi.org/10.1046/j.1432-1033.2003.03593.x
- Ni N., Li Q. TGFβ superfamily signaling and uterine decidualization // Reprod. Biol. Endocrinol. 2017. V. 15. № 1. P. 1. https://doi.org/10.1186/s12958-017-0303-0
- Ochsner U.A., Green L.S., Rice T.P. et al. Targeting Unique Epitopes on Highly Similar Proteins GDF-11 and GDF-8 with Modified DNA Aptamers // Biochemistry. 2019. V. 58. № 46. P. 4632. https://doi.org/10.1021/acs.biochem.9b00760
- Olson K.A., Beatty A.L., Heidecker B. et al. Association of growth differentiation factor 11/8, putative anti-ageing factor, with cardiovascular outcomes and overall mortality in humans: analysis of the Heart and Soul and HUNT3 cohorts // Eur. Heart J. 2015. V. 36. № 48. P. 3426. https://doi.org/10.1093/eurheartj/ehv385
- Ozek C., Krolewski R.C., Buchanan S.M. et al. Growth Differentiation Factor 11 treatment leads to neuronal and vascular improvements in the hippocampus of aged mice // Sci. Rep. 2018. V. 8. № 1. P. 17293. https://doi.org/10.1038/s41598-018-35716-6
- Padyana A.K., Vaidialingam B., Hayes D.B. et al. Crystal structure of human GDF11 // Acta Crystalorg. F Struct. Biol Commun. 2016. № 72 (Pt 3). P. 160. https://doi.org/10.1107/S2053230X16001588
- Patel V.K., Demontis F. GDF11/myostatin and aging // Aging (Albany NY). 2014. V. 6. №5. P. 351. https://doi.org/10.18632/aging.100666
- Poggioli T., Vujic A., Yang P. et al. Circulating growth differentiation factor 11/8 levels decline with age // Circ. Res. 2016. V. 118. № 1. P. 29. https://doi.org/10.1161/CIRCRESAHA.115.307521
- Robertson IB, Horiguchi M, Zilberberg L. et al. Latent TGF-β-binding proteins // Matrix Biol. 2015. V. 47. P. 44-53. https://doi.org/10.1016/j.matbio.2015.05.005
- Rodgers B.D. The immateriality of circulating GDF11 // Circ. Res. 2016. V. 118. № 10. P. 1472. https://doi.org/10.1161/CIRCRESAHA.116.308478
- Rojas-Vázquez S., Blasco-Chamarro L., López-Fabuel I. et al. Vascular senescence: a potential bridge between physiological aging and neurogenic decline // Front. Neurosci. 2021. V. 15. P. 666881. https://doi.org/10.3389/fnins.2021.666881
- Roubenoff R., Hughes V.A. Sarcopenia: current concepts // J. Gerontol. A. Biol. Sci. Med. Sci. 2000. V. 55. № 12. P. M716. https://doi.org/10.1093/gerona/55.12.m716
- Sakai S., Ohhata T., Kitagawa K. et al. Long noncoding RNA ELIT-1 Acts as a Smad3 cofactor to facilitate TGFβ/Smad signaling and promote Epithelial–mesenchymal TRansition // Cancer Res. 2019. V. 79. № 11. P. 2821. https://doi.org/10.1158/0008-5472.CAN-18-3210
- Schafer M.J., Atkinson E.J., Vanderboom P.M. et al. Quantification of GDF11 and myostatin in human aging and cardiovascular disease // Cell. Metabol. 2016. V. 23. № 6. P. 1207. https://doi.org/10.1016/j.cmet.2016.05.023
- Schafer M.J., Le Brasseur N.K. The influence of GDF11 on brain fate and function // Geroscience. 2019. V. 41. №1. P. 1. https://doi.org/10.1007/s11357-019-00054-6
- Semba R.D., Zhang P., Zhu M. et al. Relationship of circulating growth and differentiation factors 8 and 11 and their antagonists as measured using liquid chromatography-tandem mass spectrometry with age and skeletal muscle strength in healthy adults // J. Gerontol. Biol. Sci. Med. Sci. 2019. V. 74. № 1. P. 129–136. https://doi.org/10.1093/gerona/gly255
- Shen G.S., Zhou H.B., Zhang H. et al. The GDF11-FTO-PPARγ axis controls the shift of osteoporotic MSC fate to adipocyte and inhibits bone formation during osteoporosis // Biochim. Biophys. Acta Mol. Basis Dis. 2018. V. 1864. № 12. P. 3644. https://doi.org/10.1016/j.bbadis.2018.09.015
- Shi Y., Liu J.P. Gdf11 facilitates temporal progression of neurogenesis in the developing spinal cord // J. Neurosci. 2011. V. 31. № 3. P. 883. https://doi.org/10.1523/JNEUROSCI.2394-10.2011
- Simoni-Nieves A., Gerardo-Ramírez M., Pedraza-Vázquez G. et al. GDF11 Implications in Cancer Biology and Metabolism. Facts and Controversies // Front. Oncol. 2019. № 9. P. 1039. https://doi.org/10.3389/fonc.2019.01039
- Sinha M., Jang Y.C., Oh J. et al. Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle // Science. 2014. V. 344. № 6184. P. 649. https://doi.org/10.1126/science.1251152
- Smith S.C., Zhang X., Zhang X., et al. GDF11 does not rescue aging-related pathological hypertrophy // Circ. Res. 2015. V. 117. № 11. P. 926. https://doi.org/10.1161/CIRCRESAHA.115.307527
- Suh J., Kim N.K., Lee S.H. et al. GDF11 promotes osteogenesis as opposed to MSTN, and follistatin, a MSTN/GDF11 inhibitor, increases muscle mass but weakens bone // Proc. Natl. Acad. Sci. 2020. V. 117. №. 9. P. 4910. https://doi.org/10.1073/pnas.1916034117
- Suh J., Lee Y.S. Similar sequences but dissimilar biological functions of GDF11 and myostatin // Exp. Mol. Med. 2020. V. 52. № 10. P. 1673. https://doi.org/10.1038/s12276-020-00516-4
- Suzuki Y., Takaya K., Watanabe S. et al. Evaluation of the effect of age of the younger mice on the rejuvenation of the older mice by heterochronic parabiosis // Aging (Albany NY). 2022. V. 14. № 6. P. 2507. https://doi.org/10.18632/aging.203966
- Tamayo E., Alvarez P., Merino R. TGFβ superfamily members as regulators of B cell development and function – implications for autoimmunity // Int. J. Mol. Sci. 2018. V. 19. № 12. P. 3928. https://doi.org/10.3390/ijms19123928
- Tian J., Lei X.X., Xuan L. et al. The effects of aging, diabetes mellitus, and antiplatelet drugs on growth factors and anti-aging proteins in platelet-rich plasma // Platelets. 2019. V. 30. № 6. P. 773-792. https://doi.org/10.1080/09537104.2018.1514110
- Trexler M., Bányai L., Patthy L. Distinct expression pattern of two related human proteins containing multiple types of protease-inhibitory modules // Bio. Chem. 2002. V. 383. № 1. P. 223. https://doi.org/10.1515/BC.2002.023
- Tsuda T., Iwai N., Deguchi E. et al. PCSK5 and GDF11 expression in the hindgut region of mouse embryos with anorectal malformations // Eur. J. Pediatr. Surg. 2011. V. 21. № 4. P. 238. https://doi.org/10.1055/s-0031-1273691
- Walker R.G., Czepnik M., Goebel E.J. et al. Structural basis for potency differences between GDF8 and GDF11 // BMC Biol. 2017. V. 15. № 1. P. 19. https://doi.org/10.1186/s12915-017-0350-1
- Walker R.G., Poggioli T., Katsimpardi L. et al. Biochemistry and Biology of GDF11 and Myostatin: Similarities, Differences, and Questions for Future Investigation // Circ. Res. 2016. V. 118. № 7. P. 1125. https://doi.org/10.1161/CIRCRESAHA.116.308391
- Wallner C., Drysch M., Becerikli M. et al. Interaction with the GDF8/11 pathway reveals treatment options for adenocarcinoma of the breast // Breast. 2018. № 37. P. 134. https://doi.org/10.1016/j.breast.2017.11.010
- Wang F., Shen X., Li S. et al. Splenocytes derived from young WT mice prevent AD progression in APPswe/PSENldE9 transgenic mice // Oncotarget. 2015. V. 6. № 25. P. 20851. https://doi.org/10.18632/oncotarget.4930
- Wu H.H., Ivkovic S., Murray R.C. et al. Autoregulation of neurogenesis by GDF11 // Neuron. 2003. V. 37. № 2 P. 197. https://doi.org/10.1016/s0896-6273(02)01172-8
- Wu Y., Qu J., Li H. et al. Relationship between serum level of growth differentiation factors 8, 11 and bone mineral density in girls with anorexia nervosa // Clin. Endocrinol. 2019. V. 90. № 1. P. 88. https://doi.org/10.1111/cen.13871
- Xie J., Zhu H., Chang H.M. et al. GDF8 promotes the cell invasiveness in human trophoblasts by upregulating the expression of follistatin-like 3 through the ALK5-SMAD2/3 signaling pathway // Front. Cell Develop. Biology. 2020. V. 8. P. 573781. https://doi.org/10.3389/fcell.2020.573781
- Yang R., Fu S., Zhao L. et al. Quantitation of circulating GDF-11 and β2-MG in aged patients with age-related impairment in cognitive function // Clin. Sci. (Lond). 2017. V. 131. № 15. P. 1895. https://doi.org/10.1042/CS20171028
- Yokoe T., Ohmachi T., Inoue H. et al. Clinical significance of growth differentiation factor 11 in colorectal cancer // Int. J. Oncol. 2007. V. 31. № 5. P. 1097.
- Zhang J., Li Y., Li H. et al. GDF11 Improves Angiogenic Function of EPCs in Diabetic Limb Ischemia // Diabetes. 2018. V. 67. № 10. P. 2084. https://doi.org/10.2337/db17-1583
- Zhang M., Jadavji N.M., Yoo H.S. et al. Recombinant growth differentiation factor 11 influences short-term memory and enhances Sox2 expression in middle-aged mice // Behav. Brain. Res. 2018. № 341. P. 45. https://doi.org/10.1016/j.bbr.2017.12.019
- Zhang W., Guo Y., Li B. et al. GDF11 Rejuvenates Cerebrovascular Structure and Function in an Animal Model of Alzheimer’s Disease // J. Alzheimers. Dis. 2018. V. 62. № 2. P. 807. https://doi.org/10.3233/JAD-170474
- Zhang Y., Shao J., Wang Z. et al. Growth differentiation factor 11 is a protective factor for osteoblastogenesis by targeting PPARgamma // Gene. 2015. V. 557. № 2. P. 209. https://doi.org/10.1016/j.gene.2014.12.039
- Zhang Y., Wei Y., Liu D. et al. Role of growth differentiation factor 11 in development, physiology and disease // Oncotarget. 2017. V. 8. № 46. P. 81604. https://doi.org/10.18632/oncotarget.20258
- Zhang Y.H., Pan L.H., Pang Y. et al. GDF11/BMP11 as a novel tumor marker for liver cancer // Exp. Ther. Med. 2018. V. 15. № 4. P. 3495–3500. https://doi.org/10.3892/etm.2018.5861
- Zhao Y., Wang L.H., Peng A. et al. The neuroprotective and neurorestorative effects of growth differentiation factor 11 in cerebral ischemic injury // Brain Res. 2020. № 1737. P. 146802. https://doi.org/10.1016/j.brainres.2020.146802
- Zhou Y., Sharma N., Dukes D. et al. GDF11 treatment attenuates the recovery of skeletal muscle function after injury in older rats // AAPS J. 2017. V. 19. № 2. P. 431-437. https://doi.org/10.1208/s12248-016-0024-x
- Zimmers T.A., Jiang Y., Wang M. et al. Exogenous GDF11 induces cardiac and skeletal muscle dysfunction and wasting // Basic Res. Cardiol. 2017. V. 112. № 4. P. 48. https://doi.org/10.1007/s00395-017-0639-9
- Zou M.L., Chen Z.H., Teng Y.Y. et al. The Smad dependent TGF-β and BMP signaling pathway in bone remodeling and therapies // Front. Mol. Biosci. 2021. V. 8. P. 593310. https://doi.org/10.3389/fmolb.2021.593310